[分子向治疗EGFR突变状细胞肺癌的进展]
Bingwan Xiong1, Wenfei Ke1, Wenyang Jiang1
1Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
概括
对EGFR突变肺状癌的向治疗显示出有前途. 本综述总结了针对这种特定肺癌亚型的表皮生长因子受体 (EGFR) 氨酸激酶抑制剂 (TKI) 的最新发现.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 非小细胞肺癌 (NSCLC) 是一种常见的恶性瘤.
- 肺状癌是一种主要的NSCLC亚型.
- 表皮生长因子受体 (EGFR) 突变驱动肺癌,但在状细胞癌中比腺癌更少.
研究的目的:
- 审查最近对EGFR突变肺状癌的分子向治疗研究.
- 要总结EGFR-氨酸激酶抑制剂 (TKI) 在这个患者群体中的疗效.
- 为治疗EGFR突变肺状癌提供临床参考.
主要方法:
- 最近研究的文献综述.
- 对EGFR-TKI临床试验数据的分析.
- 综合关于治疗疗效的信息.
主要成果:
- EGFR-TKIs在肺状癌中表现出不同的疗效.
- 特定的突变和TKI代对结果产生影响.
- 对这种亚型的向治疗的进展正在进行中.
结论:
- 突变EGFR的肺状癌是一种独特的临床实体.
- 使用EGFR-TKI的向治疗提供了一个治疗选择.
- 需要进一步的研究来优化治疗策略.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
7.9K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.8K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K